Showing results (351-360 of 369) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european studyFabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2022
Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Annals of Surgical Oncology|June 29, 2022
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W Tseng, Carol J Swallow, Dirk C Strauss, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
The American Journal of Surgical Pathology|October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized DiseaseClaudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
Pageof 37